Anna Abram

Anna Abram is the FDA’s deputy commissioner for policy, planning, legislation, and analysis.

Mon, 10/02/2017 - 12:02
FDA Seeks Public Input on Modernizing Regulatory FrameworkPublic dockets will solicit feedback from patients, consumers, health providers, and state governments
Mon, 10/02/2017 - 12:02
We’re at a moment of extraordinary opportunity to improve public health. New innovations are giving us fundamentally better ways to address disease. Some of the same technology is providing consumers with a broader selection of foods that can…